Diamond-shaped crystal deal toy commemorating a follow-on stock offering by Swiss biotech firm Oculis. (23AKL262)
Diamond-shaped crystal deal toy commemorating a follow-on stock offering by Swiss biotech firm Oculis. (23AKL262)
Side view of crystal financial tombstone marking a follow-on offering by Oculis. Headquartered in Geneva, the biopharmaceutical firm specializes in eye care products and treatments.
Back view of diamond-shaped deal tombstone recognizing a public offering by Oculis. The ophthalmic biopharmaceutical company addresses a number of conditions, including diabetic macular edema, dry eye disease, and glaucoma.